Genome-wide DNA methylation assessment of ‘BRCA1-like’ early-onset breast cancer

Data from the Australian Breast Cancer Family Registry

Cameron M. Scott, Ee Ming Wong, Ji Hoon Eric Joo, Pierre Antoine Dugué, Chol Hee Jung, Neil O'Callaghan, James Dowty, Graham G. Giles, John L. Hopper, Melissa C. Southey

Research output: Contribution to journalArticleResearchpeer-review

1 Citation (Scopus)

Abstract

Breast cancers arising in women carrying a germline mutation in BRCA1 are typically high-grade, early-onset and have distinct morphological features (BRCA1-like). However, the majority of early-onset breast cancers of this morphological type are not associated with germline BRCA1 mutations or constitutional BRCA1 promoter methylation. We aimed to assess DNA methylation across the genome for associations with the “BRCA1-like” morphology. Genome-wide methylation in blood-derived DNA was measured using the Infinium HumanMethylation450K BeadChip assay for women under the age of 40 years participating in the Australian Breast Cancer Family Study (ABCFS) diagnosed with: i) BRCA1-like breast cancer (n = 30); and ii) breast cancer without BRCA1-like morphological features (non BRCA1-like; n = 30), and age-matched unaffected women (controls; n = 30). Corresponding tumour-derived DNA from 43 of the affected women was also assessed. Methylation of blood-derived DNA was found to be elevated across 17 consecutive marks in the BRCA1 promoter region and decreased at several other genomic regions (including TWIST2 and CTBP1) for 7 women (23%) diagnosed with BRCA1-like breast cancer compared with women in the other groups. Corresponding tumour-derived DNA available from 5 of these 7 women had elevated methylation within the BRCA1 and SPHK2 promoter region and decreased methylation within the ADAP1, IGF2BP3 and SPATA13 promoter region when compared with the other breast tumours. These methylation marks could be biomarkers of risk for BRCA1-like breast cancer, and could be responsible in part for their distinctive morphological features and biology. As such, they may assist with prevention and targeted therapies for this cancer subtype.

Original languageEnglish
Pages (from-to)404-410
Number of pages7
JournalExperimental and Molecular Pathology
Volume105
Issue number3
DOIs
Publication statusPublished - 1 Dec 2018

Keywords

  • BRCA1
  • Early-Onset Breast Cancer
  • Genome-Wide
  • HM450K
  • Methylation

Cite this

Scott, Cameron M. ; Wong, Ee Ming ; Joo, Ji Hoon Eric ; Dugué, Pierre Antoine ; Jung, Chol Hee ; O'Callaghan, Neil ; Dowty, James ; Giles, Graham G. ; Hopper, John L. ; Southey, Melissa C. / Genome-wide DNA methylation assessment of ‘BRCA1-like’ early-onset breast cancer : Data from the Australian Breast Cancer Family Registry. In: Experimental and Molecular Pathology. 2018 ; Vol. 105, No. 3. pp. 404-410.
@article{1587e21b3a82426fa848a8ede46597dd,
title = "Genome-wide DNA methylation assessment of ‘BRCA1-like’ early-onset breast cancer: Data from the Australian Breast Cancer Family Registry",
abstract = "Breast cancers arising in women carrying a germline mutation in BRCA1 are typically high-grade, early-onset and have distinct morphological features (BRCA1-like). However, the majority of early-onset breast cancers of this morphological type are not associated with germline BRCA1 mutations or constitutional BRCA1 promoter methylation. We aimed to assess DNA methylation across the genome for associations with the “BRCA1-like” morphology. Genome-wide methylation in blood-derived DNA was measured using the Infinium HumanMethylation450K BeadChip assay for women under the age of 40 years participating in the Australian Breast Cancer Family Study (ABCFS) diagnosed with: i) BRCA1-like breast cancer (n = 30); and ii) breast cancer without BRCA1-like morphological features (non BRCA1-like; n = 30), and age-matched unaffected women (controls; n = 30). Corresponding tumour-derived DNA from 43 of the affected women was also assessed. Methylation of blood-derived DNA was found to be elevated across 17 consecutive marks in the BRCA1 promoter region and decreased at several other genomic regions (including TWIST2 and CTBP1) for 7 women (23{\%}) diagnosed with BRCA1-like breast cancer compared with women in the other groups. Corresponding tumour-derived DNA available from 5 of these 7 women had elevated methylation within the BRCA1 and SPHK2 promoter region and decreased methylation within the ADAP1, IGF2BP3 and SPATA13 promoter region when compared with the other breast tumours. These methylation marks could be biomarkers of risk for BRCA1-like breast cancer, and could be responsible in part for their distinctive morphological features and biology. As such, they may assist with prevention and targeted therapies for this cancer subtype.",
keywords = "BRCA1, Early-Onset Breast Cancer, Genome-Wide, HM450K, Methylation",
author = "Scott, {Cameron M.} and Wong, {Ee Ming} and Joo, {Ji Hoon Eric} and Dugu{\'e}, {Pierre Antoine} and Jung, {Chol Hee} and Neil O'Callaghan and James Dowty and Giles, {Graham G.} and Hopper, {John L.} and Southey, {Melissa C.}",
year = "2018",
month = "12",
day = "1",
doi = "10.1016/j.yexmp.2018.11.006",
language = "English",
volume = "105",
pages = "404--410",
journal = "Experimental and Molecular Pathology",
issn = "0014-4800",
publisher = "Elsevier",
number = "3",

}

Genome-wide DNA methylation assessment of ‘BRCA1-like’ early-onset breast cancer : Data from the Australian Breast Cancer Family Registry. / Scott, Cameron M.; Wong, Ee Ming; Joo, Ji Hoon Eric; Dugué, Pierre Antoine; Jung, Chol Hee; O'Callaghan, Neil; Dowty, James; Giles, Graham G.; Hopper, John L.; Southey, Melissa C.

In: Experimental and Molecular Pathology, Vol. 105, No. 3, 01.12.2018, p. 404-410.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Genome-wide DNA methylation assessment of ‘BRCA1-like’ early-onset breast cancer

T2 - Data from the Australian Breast Cancer Family Registry

AU - Scott, Cameron M.

AU - Wong, Ee Ming

AU - Joo, Ji Hoon Eric

AU - Dugué, Pierre Antoine

AU - Jung, Chol Hee

AU - O'Callaghan, Neil

AU - Dowty, James

AU - Giles, Graham G.

AU - Hopper, John L.

AU - Southey, Melissa C.

PY - 2018/12/1

Y1 - 2018/12/1

N2 - Breast cancers arising in women carrying a germline mutation in BRCA1 are typically high-grade, early-onset and have distinct morphological features (BRCA1-like). However, the majority of early-onset breast cancers of this morphological type are not associated with germline BRCA1 mutations or constitutional BRCA1 promoter methylation. We aimed to assess DNA methylation across the genome for associations with the “BRCA1-like” morphology. Genome-wide methylation in blood-derived DNA was measured using the Infinium HumanMethylation450K BeadChip assay for women under the age of 40 years participating in the Australian Breast Cancer Family Study (ABCFS) diagnosed with: i) BRCA1-like breast cancer (n = 30); and ii) breast cancer without BRCA1-like morphological features (non BRCA1-like; n = 30), and age-matched unaffected women (controls; n = 30). Corresponding tumour-derived DNA from 43 of the affected women was also assessed. Methylation of blood-derived DNA was found to be elevated across 17 consecutive marks in the BRCA1 promoter region and decreased at several other genomic regions (including TWIST2 and CTBP1) for 7 women (23%) diagnosed with BRCA1-like breast cancer compared with women in the other groups. Corresponding tumour-derived DNA available from 5 of these 7 women had elevated methylation within the BRCA1 and SPHK2 promoter region and decreased methylation within the ADAP1, IGF2BP3 and SPATA13 promoter region when compared with the other breast tumours. These methylation marks could be biomarkers of risk for BRCA1-like breast cancer, and could be responsible in part for their distinctive morphological features and biology. As such, they may assist with prevention and targeted therapies for this cancer subtype.

AB - Breast cancers arising in women carrying a germline mutation in BRCA1 are typically high-grade, early-onset and have distinct morphological features (BRCA1-like). However, the majority of early-onset breast cancers of this morphological type are not associated with germline BRCA1 mutations or constitutional BRCA1 promoter methylation. We aimed to assess DNA methylation across the genome for associations with the “BRCA1-like” morphology. Genome-wide methylation in blood-derived DNA was measured using the Infinium HumanMethylation450K BeadChip assay for women under the age of 40 years participating in the Australian Breast Cancer Family Study (ABCFS) diagnosed with: i) BRCA1-like breast cancer (n = 30); and ii) breast cancer without BRCA1-like morphological features (non BRCA1-like; n = 30), and age-matched unaffected women (controls; n = 30). Corresponding tumour-derived DNA from 43 of the affected women was also assessed. Methylation of blood-derived DNA was found to be elevated across 17 consecutive marks in the BRCA1 promoter region and decreased at several other genomic regions (including TWIST2 and CTBP1) for 7 women (23%) diagnosed with BRCA1-like breast cancer compared with women in the other groups. Corresponding tumour-derived DNA available from 5 of these 7 women had elevated methylation within the BRCA1 and SPHK2 promoter region and decreased methylation within the ADAP1, IGF2BP3 and SPATA13 promoter region when compared with the other breast tumours. These methylation marks could be biomarkers of risk for BRCA1-like breast cancer, and could be responsible in part for their distinctive morphological features and biology. As such, they may assist with prevention and targeted therapies for this cancer subtype.

KW - BRCA1

KW - Early-Onset Breast Cancer

KW - Genome-Wide

KW - HM450K

KW - Methylation

UR - http://www.scopus.com/inward/record.url?scp=85056659753&partnerID=8YFLogxK

U2 - 10.1016/j.yexmp.2018.11.006

DO - 10.1016/j.yexmp.2018.11.006

M3 - Article

VL - 105

SP - 404

EP - 410

JO - Experimental and Molecular Pathology

JF - Experimental and Molecular Pathology

SN - 0014-4800

IS - 3

ER -